StonvexLoading…
StonvexStonvexStonvexCore line items from MAR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.65B | $26.19B | $19.50B | $13.01B |
Operating Income | $1.06B | $4.14B | $3.36B | $2.18B |
Net Income | $648.00M | $2.60B | $2.16B | $763.00M |
EPS (Diluted) | $2.43 | $9.51 | $7.84 | $5.17 |
Total Assets | $27.86B | $27.54B | $27.83B | $27.34B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $454.00M | $358.00M | $678.00M | $671.00M |
Free Cash Flow OCF − CapEx | $728.00M | $2.61B | $1.95B | $1.00B |
Shares Outstanding | 266.80M | 265.86M | 275.00M | 276.20M |